BREAKING NEWS | Important Update from Eudravigilance!

July 13, 2023

According to a recent communication from Eudravigilance, action is required from owners of development substance data in xEVMPD by the 1st of September, 2023.

If you are a Marketing Authorization Holder (MAH) of Investigational Medicinal Products (IMPs), you should retrieve your products’ information and identify the substance classification:

  • For unmapped substance data, request the creation of a new approved substance.
  • For mapped substance data, replace the development substance data.


Please note that if actions are not taken before THE 1st of September, 2023, the EMA will perform the product update on your behalf, referencing only approved substance(s).

Our team at Asphalion can assist you with the implementation of the requested actions. Don’t hesitate to reach out to us for support!!

For further information, you can contact us at:

Search News & Events

  • Filter by category


Related news and events

US FDA | SD File

The SDF is an extensible, portable text file encoding computer-readable chemical structures linked to associated data fields. Is also commonly called an SD File or

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting